CervoMed
CRVO
36 hedge funds and large institutions have $6.97M invested in CervoMed in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 17 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
4.71% less ownership
Funds ownership: 23.82% → 19.11% (-4.7%)
25% less funds holding
Funds holding: 48 → 36 (-12)
60% less capital invested
Capital invested by funds: $17.4M → $6.97M (-$10.4M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.39M |
| 2 |
Millennium Management
New York
|
+$776K |
| 3 |
Renaissance Technologies
New York
|
+$334K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$147K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$6.28M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$389K |
| 3 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$233K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$209K |
| 5 |
HF
HRT Financial
New York
|
-$113K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$8 | -1 | Closed |
|
52
Citigroup
New York
| – | -$8 | -1 | Closed |
|
|
DIG
53
Dauntless Investment Group
Etna,
New Hampshire
| – | -$8 | -1 | Closed |
|
CRVO Hedge Fund Activity: Q1 2026 in Review
36 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2026, worth a combined $6.97M — down 60% from $17.4M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CRVO and 6 opened new positions — a net loss of 11 holders — while 6 trimmed existing stakes and 10 added.
The largest buyer was Morgan Stanley, adding an estimated $1.39M. The largest seller was AWM Investment Company, exiting entirely with an estimated $6.28M sold.
- 36 institutional investors held CervoMed (CRVO) as of Q1 2026, down from 48 in Q4 2025.
- Funds reported $6.97M of CervoMed stock for Q1 2026, down 60% quarter-over-quarter.
- 6 funds opened new CervoMed positions in Q1 2026 and 17 closed out, a net change of -11 holders.
- The largest CervoMed buyer in Q1 2026 was Morgan Stanley, an estimated $1.39M added.
- The largest CervoMed seller in Q1 2026 was AWM Investment Company, an estimated $6.28M sold.
Based on aggregated 13F filings for Q1 2026.